Pistachios protect against a cause of blindness

28 April 2009

Pistachios are much more than a great-tasting snack. The little green nuts may do more for the heart, blood sugar and waistline than many  other snack food choices, according to research presented at  Experimental Biology 2009 in New Orleans, USA. Researchers from UCLA and  the University of Toronto in Canada presented, for the first time, their  findings from human clinical trials showing major health benefits from  eating pistachios.

Pistachios - the "skinny" nut

Several studies have previously shown that pistachios - and tree nuts in  general - do not contribute to overweight or obesity, when consumed in  moderation. In fact, more recent studies suggest that nut consumption is  linked to a lower body mass index - a marker for overweight and obesity,  and pistachios are thought to provide a high satiety value that may  help curb appetite, making adherence to a calorie-reduced diet easier.  The UCLA researchers set out to determine if equal amounts of calories  from either pistachios or pretzels would result in any metabolic or  anthropometric differences, when given as part of a calorie-controlled,  three-month weight loss diet.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight